Synergy CHC (SNYR) EBITDA Margin (2014 - 2025)

Synergy CHC (SNYR) posted quarterly EBITDA Margin of 219.45% for Q4 2025, down 1473.3% quarter-over-quarter from 15.98% in Q3 2025.

Synergy CHC (SNYR) EBITDA Margin (2014 - 2025) Analysis & Trends

Synergy CHC's EBITDA Margin history runs 10 years deep, the most recent figure standing at 219.45% for Q4 2025.

In Q4 2025, EBITDA Margin changed N/A year-over-year to 219.45%; the TTM figure through Dec 2025 stood at 29.89% (down 4264.0% YoY), while the FY2025 annual figure was 27.84%, down 3071.0% from the prior year.
EBITDA Margin for Q4 2025 stood at 219.45%, down from 15.98% in the prior quarter.
The five-year high for EBITDA Margin was 200.0% in Q1 2025, with the low at 219.45% in Q4 2025.
The 3-year median for EBITDA Margin is 19.73% (2024), against an average of 31.56%.
The sharpest annual moves came in 2024 and 2025: EBITDA Margin sank 514 bps in 2024, then surged 18079 bps in 2025.
Synergy CHC's EBITDA Margin stood at 33.49% in 2023, then plunged by 56 bps to 14.75% in 2024, then plunged by 1588 bps to 219.45% in 2025.
Business Quant data shows SNYR's EBITDA Margin at 219.45% in Q4 2025, 15.98% in Q3 2025, and 180.42% in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	EBITDA Margin (Qtr)
1	Mckesson	101.82 Bn	96.65 Bn	3.69 Bn	1.25%
2	Cencora	61.44 Bn	58.62 Bn	3.61 Bn	1.50%
3	Cardinal Health	54.29 Bn	49.44 Bn	2.56 Bn	1.14%
4	Henry Schein	10.04 Bn	9.89 Bn	1.10 Bn	4.95%
5	Akso Health	820.26 Mn	820.04 Mn	-	-
6	Edap Tms	157.99 Mn	136.45 Mn	7.34 Mn	-60.84%
7	Accendra Health	94.72 Mn	87.07 Mn	263.41 Mn	-5.73%
8	111	30.87 Mn	109.39 Mn	18.18 Mn	-0.84%
9	Cosmos Health	13.48 Mn	11.03 Mn	1.51 Mn	-14.82%
10	Synergy CHC	992,672.56	-1.80 Mn	2.22 Mn	-219.45%

Download Data